Enterprise Innovation Institute

Novo Nordisk commits $25m to CARB-X to combat drug-resistant infections

Posted on: January 9, 2024

The Novo Nordisk Foundation is committing up to $25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections.

Read full post: Read More